Here are three takeaways:
1. Bioventus Surgical has numerous offerings for bone healing and spine fusion including allograft bone, synthetic bone graft substitutes and cell and marrow extraction needles.
2. There are eight new products in the expanded portfolio.
3. Senior Vice President Henry Tung, MD, said, “The Bioventus Surgical portfolio is designed to meet the needs of surgeons and their patients across a broad range of clinical situations, procedures and costs.”
More articles on devices and implants:
Global cervical total disc replacement device market to reach $1.8B by 2021 – 5 observations
Stryker celebrates completion of 100K joint replacement with Mako System – 3 points
Bioventus’ LIPUS an alternative to established nonunion fracture surgery: 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
